Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: A Gynecologic Oncology Group study
Maurie Markman(The University of Texas MD Anderson Cancer Center), John A. Blessing(Roswell Park Comprehensive Cancer Center), Stephen C. Rubin(University of Pennsylvania), Joseph P. Connor(University of Wisconsin–Madison), Parviz Hanjani(Abington Memorial Hospital), Steven Waggoner(Case Western Reserve University)
Cited by 244
Abstract
Related Papers
No related papers found
Powered by citation graph analysis